logo

PGEN

PrecigenยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

PGEN Profile

Precigen, Inc.

A clinical-stage biopharmaceutical company that develops gene and cell therapies for urgent and intractable diseases

Biological Technology
--
09/25/2018
NASDAQ Stock Exchange
143
12-31
Common stock
20374 Seneca Meadows Parkway, Germantown, Maryland
--
Precigen, Inc., an Ohio limited liability company, was founded. The company was re-registered as a Virginia corporation in 2004. Precigen, Inc., is a leader in synthetic biology, an emerging and rapidly growing discipline that applies engineering principles to biological systems. The company utilizes its suite of proprietary and complementary technologies to design, construct and regulate genetic programs, which are DNA sequences composed of key genetic components.